Skip to main content
logo
LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
47.78
+0.68 (1.44%)
Sep 2, 2026, 9:54 AM EDT - Market open

LB Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-85.69-25.21-63.1-6.28-14.35
Depreciation & Amortization
0.350.320.0900
Other Amortization
--3.223.881.64
Asset Writedown & Restructuring Costs
0.010.01---
Loss (Gain) From Sale of Investments
0.220.14-0.990.1-0
Stock-Based Compensation
10.694.193.160.30.43
Other Operating Activities
0.12-1.011.26-8.799.46
Change in Accounts Payable
19.54-0.915.021.10.13
Change in Other Net Operating Assets
-27.63-12.74-1.7-2.41-0.05
Operating Cash Flow
-82.4-35.21-53.05-12.09-2.73
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-0.44-0.05-0.77-0.03-
Investment in Securities
-44.38-39.8424-27.990.12
Investing Cash Flow
-44.82-39.8923.23-28.010.12

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
---0.7325.01
Net Debt Issued (Repaid)
---0.7325.01
Issuance of Common Stock
428.073280.020-
Other Financing Activities
-31.7-25.44-1.71-2.05-2.95
Financing Cash Flow
396.37302.5638.3233.6822.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
269.16227.478.5-6.4320.36

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-82.83-35.26-53.82-12.12-2.73
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-3.69-4.38-150.24-48.55-11.80
Levered Free Cash Flow
-53.92-27.23-28.34-6.09-
Unlevered Free Cash Flow
-53.92-27.23-28.34-6.96-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash Interest Paid
---1.98-
Cash Income Tax Paid
00000
Change in Working Capital
-8.09-13.653.31-1.310.09
SEC Filings: 10-K · 10-Q